Dose: 0.285 to 0.857 mg/kg
Single Dose: 0.57 (0.571)
Frequency: 8 hourly
Route: PO
Instructions: -

Dose: Not rexcommended in this age group
Single Dose:
Frequency:
Route:
Instructions:

Dose:
Single Dose:
Frequency:
Route:
Instructions: Not recommended in this age group

. It is of Synthetic origin and belongs to Phenyl Acetate. It belongs to Cholinergic muscarinic antagonist pharmacological group on the basis of mechanism of action and also classified in Antispasmodic Agent pharmacological group.The Molecular Weight of Camylofin is 393.40.

Camylofin is contraindicated in conditions like Glucoma,Urinary retention (adynamic bladder),Mega colon,GI hemorrhage,Tachyarrythmia,Porphyria.

The symptomatic adverse reactions produced by Camylofin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Tachycardia, Dry mouth, Redness, Disturbances of accomodation, Glaucoma, Reduced sweating.

Camylofin is primarily indicated in conditions like Angina, Biliary colic, Dysmenorrhoea, Migraine, Myocardial infarction, Pancreatitis, Renal colic, Spasticity.

No data regarding the interactions of Camylofin was found.

If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Inj, tabs Store Below 20°C.

It should be used with caution in elderly, in patients with urinary retention, prostatic enlargement, tachycardia, cardiac insufficiency, paralytic ileus, ulcerative colitis and pylonic stenosis, pregnancy and in breast feeding, May aggravate gastroesophageal reflux.